Home/Filings/4/0001728117-22-000114
4//SEC Filing

Carter Laura 4

Accession 0001728117-22-000114

CIK 0001728117other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 5:21 PM ET

Size

5.3 KB

Accession

0001728117-22-000114

Insider Transaction Report

Form 4
Period: 2022-12-07
Carter Laura
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-07+157,500157,500 total
    Exercise: $2.16Exp: 2032-12-06Common Stock (157,500 underlying)
Footnotes (1)
  • [F1]One-third of the total number of shares subject to the option will vest on December 7, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

Issuer

Gossamer Bio, Inc.

CIK 0001728117

Entity typeother

Related Parties

1
  • filerCIK 0001858178

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 5:21 PM ET
Size
5.3 KB